A prerequisite step in categorizing immature cells within a continuum of differentiation includes finding specific molecular markers.
In the case of GFAP-expressing cells, the S100B calciprotein could be such a marker since its expression correlates with the spatiotemporal maturation of the glial cells ( ; ; ). This hypothesis is Cicero et al., 1972 Deloulme et al., 2004 Ghandour et al., 1981 strengthened by the recent observation that S100B is not expressed in the bipolar GFAP-expressing cells present in SGL and the SVZ of adult mouse brain ( ; ; ). To determine whether the presence or the absence of Deloulme et al., 2004 Filippov et al., 2003 Garcia et al., 2004 S100B in GFAP-expressing cells is relevant to their maturation status and their NSC attributs, we have examined the expression pattern of S100B during the forebrain development. We show here, that S100B is a late marker of astrocyte development being expressed long after GFAP and characterizing a mature stage. By taking advantage of -EGFP transgenic mice, we demonstrate that the onset of S100B s100b expression in astrocytes is associated with the loss of their potential to form neurospheres. We next show that the adult subventricular environment and EGF repress S100B expression while maintaining their neurosphere forming potential . Altogether, our in vivo in vitro findings suggest that the onset of S100B expression defines a critical period in which GFAP-expressing cells acquire a more mature developmental stage and lose their neural stem cell potential.
Materials and Methods

Mice
-EGFP ( ) and -actin-GFP transgenic mice ( ) were housed under standard laboratory s100b Vives et al., 2003 β Okabe et al., 1997 conditions. C57/Bl6 mice were purchased from Charles River Laboratories (Arbresle, France). Experiments were performed according to the principles of laboratory animal care in compliance with European and French law. Mouse embryos and newborn mice (E16-P15) were
anesthetized by hypothermia and killed by decapitation.
Primary astrocytic cultures
Hemispheres from whole forebrain of P2 newborns were separated, hippocampus, fimbria and septum were excluded and the meningeal membrane was removed. Lateral ventricular zone and cortex were carefully dissected out and treated separately. Tissues were dissociated by trypsinization and mechanical trituration in Hanks balanced saline solution containing 2.5 mg/ml trypsin (Invitrogen) and 1 g/ml DNAse. Microglial cells were removed by preplating the cell suspension on non-coated Petri dishes for 15 min. The resulting cell μ suspension was then replated on non-coated Falcon Petri dishes in DMEM medium supplemented with 10 FBS. After 4 days % in vitro (DIV), oligodendrocyte progenitor cells and neuroblasts growing on top of the developing astroglial layer, were selectively removed by flushing as previously described ( ). At DIV 15 and DIV 30, non-astrocytic cell contamination was evaluated using Deloulme et al., 1990 O4 antibody, antibodies against PDGFR-and MBP for oligodendroglial cells, -tubulin III for neuronal cells, fibronectin (DAKO following primary antibodies were used: mouse hybridoma supernatants RC2 and O4 (Developmental Studies Hybridoma Bank, University of Iowa), rat monoclonal antibody (mAb) anti-GFAP (1:500, USB biological), rat mAb anti PDGFR-(1:100, Pharmingen), α mouse mAb anti-S100B (1:1500, ( ), mouse mAb anti--tubulin III (1:1000, Berkley company), rabbit polyclonal Takahashi et al., 1999 β antibodies (pAb) anti-human S100B (1:700, DAKO Cytomation), rabbit pAb anti-Olig 2 (1:1000), rabbit pAb anti-proteoglycan NG2
(1:200, Chemicon), guinea pig pAb anti-GLAST (1:8000, Chemicon). The specificity of anti-S100B antibodies was controlled on S100B / − brain sections as previously described ( ). All sections and cell preparations were permeabilized and blocked in TBS GFAP-expressing cells are able to generate primary neurospheres ( ; ). After 12 DIV, spheres were Imura et al., 2003 Laywell et al., 2000 plated on PLL-coated coverslips and either counted or induced to differentiate for 4 days by growth factor withdrawal and addition of N2 and B27 complements (1:100 and 1:200, respectively, Invitrogen) and 3 FBS.
%
FACS Sorting
15 and 30 DIV primary astrocytic cultures obtained from the forebrain of P2 newborn -EGFP mice were prepared and s100b dissociated as described above. Dissociated astrocytic cells were sorted using a MoFlo machine (Dako Cytomation). Electronic gates were defined using wild-type and GFP-astrocytic cultures derived from GFP transgenic mice. EGFP-positive and negative cells sorted from -EGFP brain tissue were counted and resuspended in neurosphere medium. In some experiments, secondary astrocytic cultures were s100b generated from sorted -EGFP negative cells.
-EGFP negative cells were plated at high density (1.10 cells/cm2) on PLL-coated s100b s100b 5 coverslips and treated every second day with 10 ng/ml EGF.
Astrocytic cell transplantation
SVZ astrocytic cultures derived from -actin-GFP mice were dissociated at 15 DIV and then injected stereotaxically (1.104 cells/2 l) β μ into the striatum or the SVZ of adult (8-week old) C57/Bl6 hosts at the following coordinates (mm) anteroposterior (AP), mediolateral (ML) and dorsoventral (DV) relative to Bregma AP/ML/DV: 0.6/2/ 3 or 0.6/1.1/ 3 respectively. After 1 or 4 weeks, brains were removed − − after intracardial perfusion of 4 PFA and stained as described above. In some experiments, grafted mice have been given an i.v. injection % of EGF (400 ng/40 l PBS) every second day, for 4 weeks.
μ
Western blot-analysis
The analysis of S100B, GFAP and -tubulin in astrocytic cell extracts was carried out using 11 SDS-Tris-Tricine polyacrylamide α % gels as previously described ( ). The commercial secondary antibodies used in Western blot were conjugated with Deloulme et al., 2000 horseradish peroxidase and proteins were visualized using ECL kit (NEN).
Cell counts and statistics
For counting, astrocytic cells were plated in 4-well Permanox slides and treated as described above. Quantitative analyses were performed by counting at least 500 cells per well. Two or 3 wells were counted for each combination of double or triple staining. The number of independent culture is indicated in legends.
, the number of counted cells and the number of mice are indicated in figure legends. For each combination staining, the In situ counting was performed on 2 to 5 slice preparations using a confocal microscope.
In neurosphere experiments, astrocytic cells were resuspended at a density of 5000 cells/ml of DMEM in 35 mm Falcon Petri dishes containing 2 ml culture medium supplemented as described above. After 12 DIV, neurospheres were sedimented, resuspended in 100 l of μ DMEM and plated in 96 well Falcon micro-plates. Neurospheres were photographed and spheres larger than 50 m were counted. Three μ dishes were plated for each point. The number of independent cultures is indicated in legends.
Statistical analysis of the raw data was performed by analysis of variance followed by Student s t test using Excel software. The values ' are considered as significant when p is <0.05.
Results
In this study, we designated astrocytes, cells that express the GFAP.
S100B expression characterizes a mature developmental stage of astrocytic lineage
During astrogliogenesis, RGCs progressively lose the nestin epitope recognized by the RC2 monoclonal antibody and acquire GFAP staining and a stellate morphology. To determine when S100B expression appears during astrogliogenesis, we analyzed and quantified its expression from after birth until adulthood in different zones of the telencephalon including the striatum, the cortex and the corpus callosum ( ). At postnatal day 2 (P2), S100B is absent from RC2 transforming RGCs which begin to express GFAP in their thin the astrocytic morphological maturation is almost completed. More than 67 at P14, and virtually all highly ramified GFAP cells in the % + adult parenchyma, express the S100B protein ( ). The late acquisition of S100B by multipolar astrocytic cells of the Fig 1E F forebrain, long after the gain of GFAP and loss of RC2 staining, is also evident on Western blots of brain extracts ( ). Together, Fig. 1G these results indicate that in astrocytic cells, S100B expression characterizes a mature developmental stage.
GFAP-expressing cells never express S100B protein in adult germinal zones
In contrast to parenchymal astrocytes, we found that astrocytes of the germinal zones do not express S100B. This is true from the onset of postnatal development ( ) until adulthood ( ), whereas the level of S100B expression progressively increases with Fig ). Because of their bipolar morphology, the lack of S100B coexpression in GFAP astrocytes of Fig 2B and C + adult germinal zones could be interpreted as these cells being locked in an immature developmental stage. However, one could not exclude the possibility that these GFAP-expressing cells constitute a specific subpopulation of cells unable to express S100B.
Subventricular GFAP-expressing cells have the potential to mature into S100B astrocytes
+ in vitro
To test whether the S100B expression onset correlates with terminal development of GFAP-expressing cells or whether GFAP cells + of SVZ constitute a specific subpopulation of astrocytic cells that are intrinsically unable to express S100B, we investigated their behavior in culture. To this end, we compared the pattern of S100B and other astroglial markers in astrocytic monolayer cultures derived from the cortex or the lateral ventricular wall of P2 mice. After 7 days in culture (DIV 7), the persistence of immature astroglial characteristics in SVZ astrocytes was evidenced by the high expression of embryonic or astroglial progenitor markers such as RC2 ( ), vimentin, Fig. 3A GLAST or nestin (data not shown). The same was found with whole cortex-derived cultures (data not shown). At this stage, only 20 of % GFAP cells express S100B (
). Then, a phenotypical transition occurs in both types of culture that is accompanied by a progressive
and drastic down regulation of RC2 ( ) and nestin expression (data not shown), the persistence of GLAST expression (data Fig. 3B and E not shown) and the generalization of GFAP and S100B expression between DIV 15 and DIV 30 ( ). At 30 DIV, more than 90 Fig. 3D and E of GFAP-expressing cells express S100B (
). There is no significant difference in the percentages of S100B , GFAP or RC2 expression analyzed by Western blot confirmed that S100B is detected later than GFAP in crude protein extracts of astrocytic cultures ( ). To determine whether the S100B expression onset correlates with the lost of their NSC potential, we took advantage of transgenic mice expressing EGFP under the control of the promoter ( ). Since S100B expression in brain was not restricted to s100b Vives et al., 2003 astrocytic lineage ( ; ) and ), we generated primary cortical astrocytic cultures Deloulme et al., 2004 Vives et al., 2003 supplemental Figure 1 from P2 -EGFP newborn mice. As expected, the number of EGFP cells increased with time spent in culture ( ). We then s100b Interestingly, an equivalent amount of neurospheres was generated from EGFP cells derived from either 15 or 30 DIV cultures ( ).
−
Fig. 4F
This indicates that old cultured astrocytes have the same differentiation potential as young astrocytes provided that they are in a EGFP in the presence of EGF/bFGF, even after 12 DIV ( ). This strongly suggests that the growth factors, at least in our Fig. 4H H1 paradigm, cannot induce the down-regulation of S100B expression nor acquisition of a multipotent stem/progenitor cell fate by de novo mature astrocytes in culture. Taken together, these results show that the onset of S100B expression defines a critical period after which the multipotent state of murine astrocytic cells is irreversibly lost.
The adult SVZ microenvironment represses the S100B expression in transplanted astrocytic cells
To determine the role of microenvironmental cues in controlling the expression of S100B
, primary astrocytic cells obtained in vivo from the SVZ of -actin-GFP mice ( ) were grafted into the adult striatum or the SVZ of C57/BL6 hosts after 15 DIV ( Together, these observations confirm that SVZ astrocytic cells have the potential to mature towards fully differentiated S100B + astrocytes. They also clearly demonstrate the major role played by the adult SVZ microenvironment in preventing the onset of S100B expression and differentiation along the astrocyte lineage.
EGF blocks the S100B expression in GFAP-expressing cells and enhances their multipotent abilities in vitro
Many reports have shown that the EGF receptor (EGF-R) signaling pathway, activated by EGF and/or TGF-, stimulates astrocyte α development and ( ; ; ). We therefore wondered whether EGF in vitro in vivo Burrows et al., 1997 Kornblum et al., 1998 Sibilia et al., 1998 could be part of the microenvironemental factors acting on S100B expression and astrocyte development. To this end, we first generated, from the SVZ of -EGFP mice, 15 DIV astrocytic primary cultures. Then EGFP cells were sorted by flow cytometry, and platted at s100b 
Discussion
The aim of the present study was to determine whether the heterogeneity of S100B expression within the GFAP expressing population might be related to their developmental status and their NSC potential. Our results can be summarized as follows. First, the onset of S100B processes of a given cell, and thus its maturation state, S100B reliably defines a late stage of GFAP cell maturation. Based on the + combined use of S100B, GFAP and RC2, one can thus distinguish three successive stages of murine astrocytic development ( ). The defines the more mature state of the neocortical astrocytes as well as . However, one should be aware that this in vivo in vitro characterization might not hold true for every species. Indeed, our preliminary results showed that the spatiotemporal pattern of forebrain S100B expression differs between mouse and rat forebrains in both the astrocytic and oligodendroglial lineages (ER and JCD, unpublished data) . In agreement with a recent report describing the post-natal development of rat and mouse SVZ ( ), we found that Peretto et al., 2005 the onset of S100B expression occurs before the onset of GFAP expression in the astrocytic lineage of rat telencephalon (our unpublished results). Therefore, in adult and developing rat brain, S100B does not discriminate immature from mature GFAP-expressing cells and might explain the presence of S100B in GFAP-expressing cell of adult rat germinal zones ( ) and our unpublished data). Namba et al., 2005 In the adult mouse germinal zones, GFAP cells are S100B . These cells have the potential to become S100B when cultured. This is
in agreement with previous studies suggesting that germinal GFAP cells belong to the astroglial lineage. Moreover, it strongly suggests + that the main differences (functional and phenotypical) between germinal zone and parenchymal astrocytes relate to their developmental stages rather than to their belonging to different astrocytic subtypes. However, we cannot exclude the existence of a subpopulation in vivo of GFAP-expressing cells harboring multiple differentiation traits except S100B expression.
Astrocytic S100B expression and neural stem cell potentials
The results of our investigations support a recent model proposing that the degree of maturation of germinal zone astrocytes is in vitro lower than that of their parenchymal counterparts ( ; ; ). Astrocytic cultures Bonaguidi et al., 2005 Garcia et al., 2004 Laywell et al., 2000 neonatally derived from the SVZ or the neocortex conserve their stem/progenitor cell potential as long as they remain S100B , and lose it − when they are S100B ( ). Furthermore, the expression pattern of S100B in developing neocortical astrocytic lineage ( ) + Fig. 4 Fig . 1 coincides with the loss of their multipotentiality which occurs during the second postnatal week ( ).
Laywell et al., 2000
Although we have demonstrated that the multipotentiality is lost when astrocytes reach the S100B stage III, our results do not allow + us to assign a specific pattern of molecular markers stage to multipotent astrocytes. It is important to note that the time spent in culture does not impact on the percentage of multipotent neurospheres generated from EGFP /S100B sorted cells ( ). This percentage, − − Fig. 4 ranging between 2.5 to 4 , is low and similar to that reported previously ( ; ). Altogether, these Nevertheless, in knock-out mice ( ), we were unable to observe morphological or functional differences s100b Xiong et al., 2000 between SVZ and parenchymal astrocytes (ER and JCD, unpublished data) . This suggests that S100B may not control stem/progenitor attributes of GFAP expressing cells. However, we and others have shown that S100B can form heterodimers with S100A1 and S100A6, two isoformes expressed in GFAP-expressing cells of the SVZ (  ;  ;  ) Therefore, functional redundancy or compensatory mechanisms might explain the lack of obvious phenotype in GFAP expressing cells of null mice. s100b
Environmental cues and astrocytic development
Adult SVZ astrocytes reside in a particular and complex microenvironment called niche which regulates inherent NSC features ( − into S100B astrocytes, the SVZ environment prevents it. We have shown that EGF treatment blocks astrocytes at stage II and increases + their capacity to generate multipotent neurospheres in culture. When injected , EGF also prevents the onset of S100B expression in in vivo grafted -actin-GFP and -EGFP astrocytic cells ( and data not shown).
β s100b Fig. 6 The physiological relevance of these results is validated by the fact that in the adult SVZ, the EGF-R is expressed in dividing progenitors as well as in some astrocytes ( ) and EGF-R signaling has been implicated in astrocytic development and in Doetsch et al., 2002 the control of adult neurogenesis ( ; ; ). Although exogenously added EGF acts Burrows et al., 1997 Kornblum et al., 1998 Sibilia et al., 1998 to maintain astrocytes in a relatively immature state, it probably is not the sole factor implicated in this process ( in vivo Bonaguidi et al., ) . we can however propose that EGF-R signaling is a key element of the SVZ niches allowing GFAP-expressing cells to remain in 2005 developmental stage II which is a necessary condition for the adequate functioning of this germinal zone.
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Figure 5
Maturation of grafted astrocytic cells is controlled by micro-environmental factors. , 15 DIV cultured astrocytic cells derived from A C -transgenic newborn mice expressing GFP under the ubiquitous -actin promoter were grafted stereotaxically in the striatum (A A1, B B1) or β --in the SVZ (C C1) of adult mice as indicated in D. GFP cells grafted in the striatum progressively expressed S100B after 1 and 4 weeks (A -+ -A1 and B B1 respectively) whereas most of GFAP /GFP cells grafted in SVZ were maintained in S100B immature state even after 4 -+ + − weeks (C C1). Arrows and arrowheads point to GFP /GFAP /S100B and GFP /GFAP /S100B respectively. , Quantitative analysis of 
Figure 7
Model of GFAP astrocytic development. The onset of GFAP expression in parallel with the progressive down-regulation of RC2 
